Our models can answer questions that would be logistically difficult outside of an in silico setting:

  • Predict outcomes from novel combination therapies
  • Simulate complex scenarios involving first-line treatment, non-response, and then second line or combination therapies
  • Predict long-term effects beyond protocol duration
  • Predict efficacy for alternative treatment strategies (dose, duration, schedule, route)
  • Optimize timing for interventions